Embryonic stem cells: Reprogramming in early embryos

March 26, 2014, Oregon Health & Science University
Embryonic stem cells (ESCs) established from an interphase 2-cell SCNT blastocyst (magnification 40x). Credit: Mitalipov laboratory at OHSU

An Oregon Health & Science University scientist has been able to make embryonic stem cells from adult mouse body cells using the cytoplasm of two-cell embryos that were in the "interphase" stage of the cell cycle. Scientists had previously thought the interphase stage—a later stage of the cell cycle—was incapable of converting transplanted adult cell nuclei into embryonic stem cells.

The findings by OHSU's Shoukhrat Mitalipov, Ph.D., and his team could have major implications for the science of generating patient-matched human embryonic for regenerative medicine. Human embryonic stem cells are capable of transforming into any cell type in the body. Scientists believe stem cell therapies hold promise for someday curing or treating a wide range of diseases and conditions—from Parkinson's disease to cardiac disease to spinal cord injuries—by replacing cells damaged through injury or illness.

Mitalipov's findings will be published March 26 in the online edition of Nature. If the new findings in mice hold true for humans, it could significantly help efforts to make rejection-proof for regenerative therapies. That's because embryonic cells that Mitalipov's team used for reprogramming—cells in the "interphase" stage—are more accessible than the traditional egg cells that are in short supply. Scientists previously had believed were capable of being produced only using the metaphase stage of egg cytoplasm.

Embryonic stem cells can be made using a process called somatic cell nuclear transfer, or SCNT, in which the nucleus from an adult cell is transferred into the cytoplasm of an unfertilized egg cell. The cytoplasmic machinery then "reprograms" that nucleus and cell into becoming an embryonic stem cell capable of transforming to any type of cell in the body.

"It has always been thought that this capacity for reprogramming ended with metaphase," said Mitalipov, senior scientist at OHSU's Oregon National Primate Research Center. "Our study shows that this reprogramming capacity remains in the later embryonic cell cytoplasm even during interphase. It looks like the factors continue working and they efficiently reprogram the cells—just as they do in metaphase."

Schematic design of the study. Both nuclei of the 2-cell mouse embryo at the interphase were replaced with somatic or embryonic cell nuclei and resulting embryos used for derivation of embryonic stem cells (ESCs) or cloned offspring. Credit: Mitalipov laboratory at OHSU

Many scientists have attempted to reprogram by interphase cytoplasm. Mitalipov and his team found success by carefully synchronizing the cell cycles of the adult cell nucleus and the recipient embryonic cytoplasm. Both had to be at an almost identical point in their respective cell cycles for the process to work, Mitalipov said.

"That was the secret," Mitalipov said. "When we did that matching, then everything worked."

Mitalipov said the next step to further his research will be to test the process in rhesus macaques.

Mitalipov has become a world scientific leader in embryonic stem cell research and in somatic cell nuclear transfer. He recently was named the director of a newly created research center at OHSU—the Center for Embryonic Cell and Gene Therapy. The center will help Mitalipov and his team accelerate their research, with expanded support from private philanthropy.

Explore further: Researchers successfully convert human skin cells into embryonic stem cells

More information: Paper: dx.doi.org/10.1038/nature13134

Related Stories

World's first chimeric monkeys are born

January 5, 2012

Researchers have produced the world's first chimeric monkeys. The bodies of these monkeys, which are normal and healthy, are composed of a mixture of cells representing as many as six distinct genomes. The advance holds great ...

Researchers test new gene therapy method in human cells

October 24, 2012

Oregon Health & Science University's development of a new gene therapy method to prevent certain inherited diseases has reached a significant milestone. Researchers at the university's Oregon National Primate Research Center ...

Researcher admits mistakes in stem cell study

May 23, 2013

A blockbuster study in which US researchers reported that they had turned human skin cells into embryonic stem cells contained errors, its lead author has acknowledged.

Recommended for you

'Zebra' tribal bodypaint cuts fly bites 10-fold: study

January 16, 2019

Traditional white-striped bodypainting practiced by indigenous communities mimics zebra stripes to reduce the number of potentially harmful horsefly bites a person receives by up to 10-fold, according to new research published ...

Big genome found in tiny forest defoliator

January 15, 2019

The European gypsy moth (EGM) is perhaps the country's most famous invasive insect—a nonnative species accidentally introduced to North America in the 1860s when a few escaped from a breeding experiment in suburban Boston. ...

Why haven't cancer cells undergone genetic meltdowns?

January 15, 2019

Cancer first develops as a single cell going rogue, with mutations that trigger aggressive growth at all costs to the health of the organism. But if cancer cells were accumulating harmful mutations faster than they could ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.